S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMASOlivier Demaria,Guillaume Habif,Francois Le Floch, Marianna Muller,Laura Chiossone,Romain Remark,Marie Vetizou, Nadia Maurel,Ariane Morel,Laurent Gauthier,Yannis Morel,Carine Paturel,Eric VivierHemaSphere（2023）引用 0|浏览13AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
